Aperçu rapide pour Trimethylguanosine Synthase 1 (TGS1) (Middle Region) Peptide (ABIN985046)
Antigène
TGS1
(Trimethylguanosine Synthase 1 (TGS1))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
Protein Region
Middle Region
Attributs du produit
This is a synthetic peptide designed for use in combination with anti-TGS1 antibody (Catalog #: ARP48923_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Concentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Conseil sur la manipulation
Avoid repeated freeze-thaw cycles.
Stock
-20 °C
Stockage commentaire
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Antigène
TGS1
(Trimethylguanosine Synthase 1 (TGS1))
Sujet
TGS1 catalyzes the methylation step(s) for the conversion of the 7-monomethylguanosine (m7G) caps of snRNAs and snoRNAs to a 2,2,7-trimethylguanosine (m(2,2,7)G) cap structure. TGS1 plays a role in transcriptional regulation.
Alias Symbols: DKFZp762A163, FLJ22995, NCOA6IP, PIMT, PIPMT
Protein Interaction Partner: SNORD3A,COIL,CREBBP,EED,EP300,NCOA6,CREBBP,EED,EP300,MED1,NCOA6